Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination
Dille De Herdt, Evy Lefevere, Véronique Brouwers, Line Hartvig, Emiel Geeraerts, Cheng-Chih Hsiao, J Q Alida Chen, Rui Pinto · 2026
Read Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination by Dille De Herdt, Evy Lefevere, Véronique Brouwers, Line Hartvig, Emiel Geeraerts, Cheng-Chih Hsiao, J Q Alida Chen, Rui Pinto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354525.txt.
Description
De Herdt and colleagues, in 2026, study a drug target that may help repair myelin, the coating that speeds signals along nerve fibers. Loss of myelin is a core harm in multiple sclerosis. A receptor called GPR17 stays switched on in young myelin-making cells after injury, and that may block them from maturing.
The team first checked human brain tissue from people with multiple sclerosis and found more of these receptor-marked cells near damaged areas. They then gave mice with toxin-caused myelin loss a new drug that blocks GPR17 by mouth. Treated mice showed faster repair in key brain and optic nerve areas. Their memory and visual signals also recovered. The results point to blocking this receptor as a possible route toward repair-focused treatment, though the work is still in animals.
Catalog record
| CREATOR | Dille De Herdt, Evy Lefevere, Véronique Brouwers, Line Hartvig, Emiel Geeraerts, Cheng-Chih Hsiao, J Q Alida Chen, Rui Pinto |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 90939 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |